2024-11-19 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis Report

**1. Performance Comparison and Divergence:**

Johnson & Johnson (JNJ), a multinational pharmaceutical and consumer goods company, has significantly underperformed the S&P 500 (VOO) over the analyzed period.  While JNJ shows a cumulative return of 35.7%, VOO boasts a 124.78% return. This results in a substantial negative divergence of -89.08%, placing it at the 4.67th percentile of the historical divergence range (max: 17.07%, min: -94.28%).  This indicates JNJ's performance has been considerably weaker than the broader market.


**2. Recent Price Movement:**

* **Closing Price:** $154.77
* **5-day Moving Average:** $153.30
* **20-day Moving Average:** $158.22
* **60-day Moving Average:** $161.77

The price is currently below all three moving averages, suggesting a short-term bearish trend.


**3. Technical Indicators and Expected Return:**

* **RSI (31.16):**  Indicates the stock is in oversold territory, suggesting potential for a rebound, but it doesn't guarantee a price increase.
* **PPO (-0.29):** Negative value suggests bearish momentum.
* **20-day Relative Divergence Change (-1.45):** Shows a recent decrease in relative strength compared to the benchmark.
* **Expected Return (0.0%):** The provided expected return is 0%, meaning no significant outperformance relative to the S&P 500 is projected over the long term (2+ years). This aligns with the historical underperformance.  Given the current price of $154.77 is not exceptionally high or low compared to recent history, there's no indication of a sharp price movement (rebound or drop).

**4. Recent Financial Performance and Outlook:**

The provided EPS and revenue figures show some volatility.  While the most recent quarter (2024-10-23) EPS of $1.12 is lower than previous quarters, it's crucial to have the expected EPS to properly assess performance.  A complete analysis requires comparison to analyst estimates and a thorough review of the company's financial statements for a comprehensive understanding of the financial health and growth prospects.  Further information is needed for a meaningful conclusion about current and future earnings.


**5. Financial Information Analysis (Revenue, Profitability and Equity):**

The provided financial data shows consistent profitability with high profit margins (above 68%) across the quarters.  However, the Return on Equity (ROE) fluctuates significantly, with a surprisingly high ROE of 36.54% in 2023-Q3, and lower figures in subsequent quarters.  This volatility needs further investigation to understand the underlying reasons.  Analyzing the balance sheet and cash flow statement would be beneficial for a deeper understanding of the company's financial health and sustainability.

**6. News and Recent Issues:**

*(This section requires accessing real-time news sources such as Shacknews and Finbold.  I cannot access real-time information.  To complete this section, please provide links to relevant news articles or reports published within the last two days.  Specifically, look for earnings reports, analyst ratings, and any other significant company news)*

**7.  Analyst Opinions and Market Outlook:**

*(This section also requires real-time information.  Please provide links to recent analyst reports and market outlooks from sources like Finbold.)*


**8. Overall Analysis Summary:**

JNJ has underperformed the S&P 500 considerably, indicating a need for deeper analysis. While the company demonstrates consistent profitability, concerns exist regarding the fluctuating ROE and the need to assess the most recent earnings against analyst expectations. The recent price movement suggests a bearish trend, although the RSI suggests the stock might be oversold.  Further research is required to determine the long-term investment viability, incorporating a thorough analysis of the recent earnings report, news, analyst opinions, and the broader market outlook. The provided data alone is insufficient for making a definitive investment recommendation.

**9.  Recommendations:**

A complete investment decision requires a much more in-depth analysis including:

* **Access and analysis of the full earnings reports**  including the comparison of actual results versus analyst expectations for the most recent quarter.
* **Review of recent news and analyst opinions** from reliable financial news sources.
* **Examination of the company's balance sheet, income statement, and cash flow statement**  to assess long-term financial health and sustainability.
* **Consideration of the broader macroeconomic environment** and its potential impact on JNJ's performance.

Based on the limited data provided, a neutral stance is warranted. More comprehensive analysis is needed before forming any strong buy, sell, or hold recommendation.
